Keynote: The State of Communications in Biotech

Session details:

The biotech industry is at a pivotal moment—where breakthrough innovation in science meets heightened public scrutiny, shifting policy environments, and increasing demands for transparency. For biotech and pharma companies, communications has never been more central to business success and public trust.

In this keynote, Fritz Bittenbender, Senior Vice President of Public Affairs and Access at Genentech, will share his perspective on the role of communicators in navigating this complex environment. He will examine the state of the industry through the lens of communications, from managing reputation and stakeholder trust to countering misinformation and shaping policy conversations.

Attendees will gain insights into:

• The key forces reshaping biotech and pharma communications today
• Best practices for building trust with patients, regulators, investors, and the public

This session will set the stage for the PR & Communications track, offering a candid look at both the challenges and opportunities ahead for communicators in life sciences.